课题基金 / 基金详情

MICROGLIA AND SIV NEUROPATHOGENESIS

MICROGLIA AND SIV NEUROPATHOGENESIS
小胶质细胞和 SIV 神经发病机制
批准号:
6393940
负责人:
KENNETH C WILLIAMS
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2003-03-31

项目摘要

项目成果

KENNETH C WILLIAMS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自摘要):本项目将测试
英文摘要
DESCRIPTION (adapted from the Abstract): This project will test the hypothesis that the perivascular macrophage is a critical cellular target in SIV infection. In the first specific aim, the Principal Investigator and his associates will determine the in vivo tropism of SIV for discrete subpopulations of brain macrophages during the progression of SIV encephalitis (SIVE). This will be performed in both retrospective and prospective studies. In the retrospective studies, the researchers will analyze animals previously infected with uncloned SIVmac251, a strain that leads to a higher percentage of animals developing SIVE than molecularly cloned strains. These studies will consist primarily of immunohistochemical analyses of banked tissue using monoclonal antibodies against a number of macrophage markers, and of differentiating perivascular brain macrophage from microglia by the differential reactivity with antibodies against CD45 and CD14. Expression of macrophage markers will be correlated with expression of SIV DNA and RNA using in situ hybridization. For the prospective studies, the researchers will isolate relatively pure populations of perivascular and parenchymal macrophages/microglia from SIVmac251-infected macaques. Infectivity will be quantified by the recovery of virus using a permissive cell line, and by quantitative PCR. For these experiments, the researchers will use animals sacrificed at two weeks after infection--a time when the Investigator believes that the predominantly infected cell is perivascular--and compare the results with animals sacrificed at later time points. In the second specific aim, the researchers will identify unique viral genotypes within the swarm of viruses used for inoculation. These studies are based on the observation that specific SIV and HIV sequences are associated with infection of target organs. To accomplish this aim, the researchers will isolate subpopulations of brain macrophages using CD14 and FACS. Viral sequences from the sorted cells will be amplified using PCR, and the genotypes for env and nef will be analyzed. The choice of genes for these experiments is based on the observation that these two genes are of particular relevance in the determination of neurotropism, as indicated in previous work from the NERPRC. The CNS macrophage tropic sequences will be inserted into an SIVmac239 backbone, and the replication in an in vitro system will then be analyzed. Ultimately, these recombinant viruses will be tested in monkeys.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERIPHERAL NEUROPATHY IN SIV-INFECTED CD8-DEPLETED RHESUS MACAQUES
  • 批准号:
    8358173
  • 项目类别:
  • 资助金额:
    $5.78万
  • 财政年份:
    2011
  • 负责人:
    KENNETH C WILLIAMS
  • 依托单位:
MONOCYTE TRAFFIC AND NEUROPATHOGENESIS OF AIDS
  • 批准号:
    8357961
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2011
  • 负责人:
    KENNETH C WILLIAMS
  • 依托单位:
MONOCYTE TRAFFIC AND NEUROPATHOGENESIS OF AIDS
  • 批准号:
    8172876
  • 项目类别:
  • 资助金额:
    $6.58万
  • 财政年份:
    2010
  • 负责人:
    KENNETH C WILLIAMS
  • 依托单位:
MONOCYTE TRAFFIC AND NEUROPATHOGENESIS OF AIDS
  • 批准号:
    7958395
  • 项目类别:
  • 资助金额:
    $11.19万
  • 财政年份:
    2009
  • 负责人:
    KENNETH C WILLIAMS
  • 依托单位:
国内基金
海外基金
基于多组学技术研究肠道微生物在猕猴(Macaca mulatta)衰老过程中的作用机制
  • 批准号:
    32370450
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    范振鑫
  • 依托单位:
藏酋猴(Macaca thibetana)体内种子传播过程中微生物菌群复合体时空动态及其作用机制研究
  • 批准号:
    32370521
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    潘慧娟
  • 依托单位:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
  • 批准号:
    32070446
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    路纪琪
  • 依托单位:
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2020
  • 负责人:
    范振鑫
  • 依托单位: